SCHEMBL25818546

SCHEMBL25818546

Clc1nc(-c2cccc(-c3ccc4ccc(-c5ccc6ccccc6c5)cc4c3)c2)nc(-c2ccc3oc4ccccc4c3c2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.40
PLA2G2A P14555 3/20 0.40
PLA2G4A P47712 3/20 0.40
PLA2G10 O15496 1/20 0.40
CASP3 P42574 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
CHEK2 O96017 1/20 0.37
NPC1 O15118 3/20 0.37
MAPT P10636 3/20 0.37
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
RAB9A P51151 2/20 0.37
HPGD P15428 2/20 0.37
HSD17B1 P14061 1/20 0.37
HSD17B2 P37059 1/20 0.37
CYP1A2 P05177 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25818509 0.99 AHR (0.41) AHRPLA2G2APLA2G4APLA2G10CASP3
SCHEMBL25818443 0.95 AHR (0.38) AHRPLA2G2APLA2G4APLA2G10CASP3
SCHEMBL25818439 0.95 PLA2G2A (0.42) AHRPLA2G2APLA2G4APLA2G10CASP3
SCHEMBL25818435 0.94 PLA2G2A (0.43) AHRPLA2G2APLA2G4APLA2G10CASP3
SCHEMBL21178372 0.94 AHR (0.45) AHRCASP3SENP7SENP6CHEK2
SCHEMBL25818551 0.93 AHR (0.43) AHRPLA2G2APLA2G4APLA2G10NPC1
SCHEMBL25818438 0.91 AHR (0.44) AHRPLA2G2APLA2G4APLA2G10NPC1
SCHEMBL25818478 0.91 PLA2G2A (0.36) AHRPLA2G2APLA2G4APLA2G10CASP3
SCHEMBL23437192 0.90 PLA2G2A (0.46) AHRPLA2G2APLA2G4APLA2G10CASP3
SCHEMBL31590787 0.90 PLA2G2A (0.46) AHRPLA2G2APLA2G4APLA2G10CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 AHR 971/4885PLA2G2A 4355/4885PLA2G4A 3970/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 AHR 971/4885PLA2G2A 4355/4885PLA2G4A 3970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.